These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6080857)

  • 1. [Considerations on a case of hyperfibrinolysis].
    Rossi A; De Petra V
    Minerva Med; 1967 Nov; 58(93):4012-5. PubMed ID: 6080857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibitors of fibrinolysis. (Our experience with epsilon-aminocaproic acid and the Kunitz inhibitor)].
    Babío San Salvador JL; Iriarte Ezcurdia JA; Ezcurra Cebreiro JM
    Rev Clin Esp; 1965 Nov; 99(4):249-52. PubMed ID: 5863279
    [No Abstract]   [Full Text] [Related]  

  • 3. Amicar and hyperfibrinolysis.
    Med Lett Drugs Ther; 1967 Jan; 9(3):10-1. PubMed ID: 6067964
    [No Abstract]   [Full Text] [Related]  

  • 4. [Epsylon-aminocaproic acid in the treatment of severe and dominating hyperfibrinolysis in a premature infant].
    Schmidt B; Pringsheim W; Künzer W
    Helv Paediatr Acta; 1980 Jul; 35(3):273-9. PubMed ID: 6773909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epsilon-aminocaproid acid in the treatment of fibrinolysis in gynecologic patients].
    Chyhrynets' II
    Pediatr Akus Ginekol; 1965; 4():50-2. PubMed ID: 5888241
    [No Abstract]   [Full Text] [Related]  

  • 6. 223. Aminocaproic acid and other inhibitors of fibrinolysis.
    McNicol GP; Douglas AS
    Practitioner; 1966 Jul; 197(177):102-11. PubMed ID: 5947080
    [No Abstract]   [Full Text] [Related]  

  • 7. [Habitual stillbirth and fibrinolysis].
    Soma H; Nakai S; Aoki T
    Nihon Sanka Fujinka Gakkai Zasshi; 1965 Mar; 17(3):235-9. PubMed ID: 5894920
    [No Abstract]   [Full Text] [Related]  

  • 8. [A case of post-scarlet fever "purpura fulminans" with hyperfibrinolysis treated with epsilon-aminocaproic acid].
    Bruni R; Avanzi G
    G Mal Infett Parassit; 1965 Dec; 17(12):832-41. PubMed ID: 5882567
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiments with the use of e-aminocaproic acid in the treatment of hemorrhagic iathesis].
    Morozova VT; Mirozhnichenko NS; Brevdo VI; Daĭkhovskiĭ BIa; Lebedeva AF; Ado MA; Dragunova NS
    Klin Med (Mosk); 1966 May; 44(5):51-5. PubMed ID: 5989396
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution on the problem of prevention and treatment of severe complications following the use of iodiene containing constrast media].
    Weill F; Weill J
    Praxis; 1968 Aug; 57(32):1112-4. PubMed ID: 4302988
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolysis and menstrual bleeding.
    Br Med J; 1970 Jan; 1(5688):61-2. PubMed ID: 5411443
    [No Abstract]   [Full Text] [Related]  

  • 12. [Essential hematuria and its treatment with fibrinolysis inhibitors].
    Zhila VV
    Vrach Delo; 1968 Feb; 2():82-5. PubMed ID: 5669369
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of fibrinolysis activation on arterial blood pressure].
    Bielawiec M; Lukjan H; Furman M; Konopiński M
    Pol Tyg Lek; 1968 May; 23(19):695-8. PubMed ID: 5670208
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenesis and prophylactic treatment of fibrinolysis in open-heart surgery.
    Kevy SV; Bernhard WF; McMahon CI
    Surg Forum; 1965; 16():65-6. PubMed ID: 5835251
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis.
    Gunawan B; Runyon B
    Aliment Pharmacol Ther; 2006 Jan; 23(1):115-20. PubMed ID: 16393288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effect of Transamin, an antiplasmin agent, in otorhinolaryngology].
    Iwasawa T
    Jibiinkoka; 1967 Feb; 39(2):195-205. PubMed ID: 6070564
    [No Abstract]   [Full Text] [Related]  

  • 17. [Massive bleeding due to hyperfibrinolysis during living-related liver transplantation for terminal liver cirrhosis; report of two cases].
    Kaku R; Matsumi M; Ichiyama M; Kajihara H; Fujii H; Ohashi I; Mizobuchi S; Morita K
    Masui; 2003 Nov; 52(11):1195-9. PubMed ID: 14661565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical aminocaproic acid (Amicar).
    Apple S
    Crit Care Nurse; 1997 Feb; 17(1):89-93. PubMed ID: 9136324
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased fibrinolysis and amyloidosis.
    Liebman H; Chinowsky M; Valdin J; Kenoyer G; Feinstein D
    Arch Intern Med; 1983 Apr; 143(4):678-82. PubMed ID: 6340622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epsilon-aminocaproic acid inhibition of fibrinolysis in vitro: should the 'therapeutic' concentration be reconsidered?
    Nielsen VG; Cankovic L; Steenwyk BL
    Blood Coagul Fibrinolysis; 2007 Jan; 18(1):35-9. PubMed ID: 17179824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.